Cytokinetics, Incorporated
IT ˙ BIT ˙ US23282W6057
62,32 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1CYTK / Cytokinetics, Incorporated
InstitutionComerica Bank
Latest Disclosed Ownership28,970 shares
Latest Disclosed Value $ 1,840,749
Comerica Bank reports 13.15% decrease in ownership of 1CYTK / Cytokinetics, Incorporated

On January 29, 2026 - Comerica Bank filed a 13F-HR form disclosing ownership of 28,970 shares of Cytokinetics, Incorporated (IT:1CYTK) valued at $1,535,410 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 33,356 shares of Cytokinetics, Incorporated. This represents a change in shares of -13.15% during the quarter. The current value of the position is $1,805,410 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F CYTOKINETICS COM NEW 23282W605 28,970 -4,386 -13.15 1,841 0.38 0.0073
2025-11-14 2025-09-30 13F CYTOKINETICS COM NEW 23282W605 33,356 -2,904 -8.01 1,833 53.01 0.0069
2025-08-14 2025-06-30 13F CYTOKINETICS COM NEW 23282W605 36,260 -206,849 -85.08 1,198 -87.74 0.0046
2025-05-14 2025-03-31 13F CYTOKINETICS COM NEW 23282W605 243,109 7,645 3.25 9,771 -11.79 0.0410
2025-02-14 2024-12-31 13F/A-1 CYTOKINETICS COM NEW 23282W605 235,464 -1,558 -0.66 11,076 -11.49 0.0447
2025-02-14 2024-12-31 13F CYTOKINETICS COM NEW 23282W605 235,464 -1,558 11,076 0.0371
2024-11-14 2024-09-30 13F CYTOKINETICS COM NEW 23282W605 237,022 70,842 42.63 12,515 39.00 0.0495
2024-08-15 2024-06-30 13F CYTOKINETICS COMMON 23282W605 166,180 35,374 27.04 9,004 -1.82 0.0375
2024-05-16 2024-03-31 13F CYTOKINETICS COMMON 23282W605 130,806 84,967 185.36 9,171 139.61 0.0395
2024-02-14 2023-12-31 13F CYTOKINETICS COMMON 23282W605 45,839 940 2.09 3,827 189.49 0.0176
2023-11-21 2023-09-30 13F CYTOKINETICS COMMON 23282W605 44,899 44,899 1,323 0.0069
2023-08-22 2023-06-30 13F CYTOKINETICS COM 23282W605 0 -56,094 -100.00 0 -100.00
2023-01-26 2022-12-31 13F CYTOKINETICS COM 23282W605 56,094 -15,935 -22.12 2 -99.94 0.0186
2022-10-28 2022-09-30 13F CYTOKINETICS COM 23282W605 72,029 -955 -1.31 3,247 11.27 0.0274
2022-08-02 2022-06-30 13F CYTOKINETICS COM 23282W605 72,984 2,267 3.21 2,918 9.12 0.0240
2022-04-27 2022-03-31 13F CYTOKINETICS COM 23282W605 70,717 905 1.30 2,674 25.66 0.0194
2022-02-18 2021-12-31 13F CYTOKINETICS COM 23282W605 69,812 -5,743 -7.60 2,128 -23.95 0.0157
2021-11-22 2021-09-30 13F CYTOKINETICS COM 23282W605 75,555 8,645 12.92 2,798 39.41 0.0169
2021-08-26 2021-06-30 13F CYTOKINETICS COM 23282W605 66,910 -4,720 -6.59 2,007 5.80 0.0120
2021-04-28 2021-03-31 13F CYTOKINETICS COM 23282W605 71,630 -2,373 -3.21 1,897 25.88 0.0113
2021-01-28 2020-12-31 13F CYTOKINETICS COM 23282W605 74,003 475 0.65 1,507 25.06 0.0096
2020-10-30 2020-09-30 13F CYTOKINETICS COM 23282W605 73,528 10,834 17.28 1,205 -19.56 0.0087
2020-07-31 2020-06-30 13F CYTOKINETICS COM 23282W605 62,694 5,471 9.56 1,498 67.00 0.0115
2020-05-01 2020-03-31 13F CYTOKINETICS COM 23282W605 57,223 2,159 3.92 897 26.69 0.0082
2020-02-07 2019-12-31 13F CYTOKINETICS COM 23282W605 55,064 295 0.54 708 16.45 0.0054
2019-10-31 2019-09-30 13F CYTOKINETICS COM 23282W605 54,769 944 1.75 608 -2.56 0.0048
2019-08-02 2019-06-30 13F CYTOKINETICS COM 23282W605 53,825 -329 -0.61 624 32.20 0.0050
2019-05-02 2019-03-31 13F CYTOKINETICS COM 23282W605 54,154 1,808 3.45 472 32.21 0.0038
2019-02-06 2018-12-31 13F CYTOKINETICS COM 23282W605 52,346 -228 -0.43 357 -6.05 0.0030
2018-11-01 2018-09-30 13F CYTOKINETICS COM 23282W605 52,574 -521 -0.98 380 -18.63 0.0031
2018-08-01 2018-06-30 13F CYTOKINETICS COM 23282W605 53,095 609 1.16 467 25.20 0.0033
2018-05-01 2018-03-31 13F CYTOKINETICS COM 23282W605 52,486 998 1.94 373 -25.25 0.0027
2018-02-02 2017-12-31 13F CYTOKINETICS COM 23282W605 51,488 -1,566 -2.95 499 -32.29 0.0033
2017-11-06 2017-09-30 13F CYTOKINETICS COM 23282W605 53,054 5,192 10.85 737 6.97 0.0053
2017-08-03 2017-06-30 13F CYTOKINETICS COM 23282W605 47,862 47,862 689 0.0052
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.